Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine/Irinotecan and Etoposide/Carboplatin in SCLC
NCT00856830Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Apr 2009
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in small cell lung cancer (SCLC), sponsored by University of Alabama at Birmingham. Started Apr 2009; status: completed.
02
Drugs
bendamustine
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00856830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00856830.